The mission of CDx Diagnostics® is to provide clinicians with easily implemented, cost-effective tools to preempt cancer through enhanced detection of precancerous cellular changes. This is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods.

Medical Devices

CDx Diagnostics®

Tom Bartel

Roger O'Sullivan

Bonnie Pirtz

Robert Tjon

Lori Bethon

Ramesh Ramasamy

Patricia Romano

Deborah Sherman

Sales and Market Development

Leadership Team

Teams at CDx Diagnostics®

Sales and Market Development

Leadership Team